protein analysis
protein analysis is a genetic therapy with 22 clinical trials. Currently 1 active trials ongoing. Historical success rate of 85.7%.
Success Metrics
Based on 12 completed trials
Phase Distribution
Phase Distribution
2
Early Stage
5
Mid Stage
0
Late Stage
Highest Phase Reached
Phase 2Trial Status & Enrollment
80.0%
12 of 15 finished
20.0%
3 ended early
1
trials recruiting
22
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Collection of Samples and Clinical Data From Patients With Amyloid Diseases
Dysferlinopathy Protein in Peripheral Blood Monocytes.
Donor Stem Cell Transplant, Pentostatin, and Total-Body Irradiation in Treating Patients With Hematological Cancer
Erlotinib and Surgery in Treating Patients With Head and Neck Cancer That Can Be Removed by Surgery
Nipple Secretion Samples in Detecting Breast Cancer in Patients and Healthy Participants Undergoing Breast Cancer Screening, Breast Diagnostic Studies, or Treatment for Benign Breast Disease
Clinical Trials (22)
Collection of Samples and Clinical Data From Patients With Amyloid Diseases
Dysferlinopathy Protein in Peripheral Blood Monocytes.
Donor Stem Cell Transplant, Pentostatin, and Total-Body Irradiation in Treating Patients With Hematological Cancer
Erlotinib and Surgery in Treating Patients With Head and Neck Cancer That Can Be Removed by Surgery
Nipple Secretion Samples in Detecting Breast Cancer in Patients and Healthy Participants Undergoing Breast Cancer Screening, Breast Diagnostic Studies, or Treatment for Benign Breast Disease
Biomarkers in Blood Samples From Patients With Acute Myeloid Leukemia
Study of Bone Marrow Samples From Patients With Acute Leukemia
Biomarkers of Response in Blood and Tumor Tissue Samples From Patients With Unresectable Stage IV Squamous Cell Cancer of the Head and Neck Previously Treated With Cetuximab, Cisplatin, and Radiation Therapy
Biomarkers in Tumor Samples From Younger Patients With Neuroblastoma
Biomarker in Tissue Samples From Patients With Ewing Sarcoma
Role of Biomarkers in Disease Progression in Samples From Patients With Acute Myeloid Leukemia
Effect of Surgery, Radiation Therapy, Chemotherapy, and Hormone Therapy on Biomarkers in Women With Stage I, Stage II, Stage III Breast Cancer, or Ductal Carcinoma In Situ That Can Be Removed By Surgery
Green Tea Extract in Treating Patients With Monoclonal Gammopathy of Undetermined Significance and/or Smoldering Multiple Myeloma
Doxorubicin Hydrochloride Liposome, Bortezomib, and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma
Studying Biomarkers in Patients With Pancreatic Cancer
Fatigue in Breast Cancer Survivors
Study of Tissue, Blood, and Urine Samples From Patients With Advanced Prostate Cancer
Study of Blood and Tissue Samples From Patients With Stomach Cancer, Esophageal Cancer, or Gastroesophageal Junction Cancer
Study of Biomarkers in Blood and/or Tumor Tissue Samples From Patients With Ductal Carcinoma in Situ and From Healthy Volunteers
Capecitabine and Streptozocin With or Without Cisplatin in Treating Patients With Unresectable or Metastatic Neuroendocrine Tumors
Drug Details
- Intervention Type
- GENETIC
- Total Trials
- 22